These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 151950)

  • 61. H-2-linked genetic control of murine T-cell-mediated lympholysis to autologous cells modified with low concentrations of trinitrobenzene sulfonate.
    Shearer GM; Schmitt-Verhulst AM; Pettinelli CB; Miller MW; Gilheany PE
    J Exp Med; 1979 Jun; 149(6):1407-23. PubMed ID: 109569
    [TBL] [Abstract][Full Text] [Related]  

  • 62. "Self-reactive" T cells. III. In vitro restimulation of T cells, "responding" in vivo or in vitro to syngeneic lymphoid cells.
    Reimann J; Diamantstein T
    Immunobiology; 1980 Dec; 157(4-5):463-73. PubMed ID: 6450160
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Cell-mediated immunity to antigens associated with murine sarcoma virus-induced tumors: augmentation of cytolytic T lymphocyte activity by successive specific and nonspecific stimulation in vitro.
    Ryser JE; Cerottini JC; Brunner KT
    Eur J Immunol; 1979 Mar; 9(3):179-84. PubMed ID: 221224
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic acid allogeneic tumors. I. Distribution of reactivity and specificity.
    Herberman RB; Nunn ME; Lavrin DH
    Int J Cancer; 1975 Aug; 16(2):216-29. PubMed ID: 50294
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Cellular requirements for the generation of primary cell-mediated lympholysis responses to Qa-1 antigens.
    Huston DP; Jenkins RN; Gresens SE; Smith R; Rich RR
    J Immunol; 1985 Apr; 134(4):2198-204. PubMed ID: 3156180
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Regulatory mechanisms in cell-mediated immune responses. VIII. Differential expression of I-region determinants by suppressor cells and their targets in suppression of mixed leukocyte reactions.
    Rich SS; David CS
    J Exp Med; 1979 Nov; 150(5):1108-21. PubMed ID: 91654
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Blocking activity of the serum from semiallogeneic chimaeras produced by means of cyclophosphamide.
    Nagurskaya EV; Chernyakhovskaya IJ; Fontalin LN
    Folia Biol (Praha); 1984; 30(4):209-20. PubMed ID: 6383881
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cell-mediated antitumor immune reactions under syngeneic conditions.
    Leclerc JC; Senik A; Gomard E; Plata F; Levy JP
    Transplant Proc; 1973 Dec; 5(4):1431-4. PubMed ID: 4359721
    [No Abstract]   [Full Text] [Related]  

  • 69. Maternal immunocompetence. II. Proliferative responses of maternal lymphocytes in vitro and inhibition by serum from pregnant rats.
    Harrison MR
    Scand J Immunol; 1976; 5(8):881-9. PubMed ID: 136741
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effects of sera from tumor-bearing mice on mitogen and allogeneic cell stimulation of normal lymphoid cells.
    Whitney RB; Levy JG
    J Natl Cancer Inst; 1975 Mar; 54(3):733-41. PubMed ID: 123599
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Antigenic strength investigated by cell-mediated lympholysis in mice.
    Abbasi K; Festenstein H
    Eur J Immunol; 1973 Jul; 3(7):430-5. PubMed ID: 4271348
    [No Abstract]   [Full Text] [Related]  

  • 72. Human pregnancy serum inhibits interleukin-2 production.
    Nicholas NS; Panayi GS; Nouri AM
    Clin Exp Immunol; 1984 Dec; 58(3):587-95. PubMed ID: 6239719
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Anti-idiotypic antibodies against UV-induced tumor-specific CTL clones. Preparation in syngeneic combination.
    Kuribayashi K; Tanaka C; Matsubayashi Y; Masuda T; Udono H; Abe M; Nakayama E; Shiku H
    J Immunol; 1988 Dec; 141(11):4074-80. PubMed ID: 2460558
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Characterization of alloimmunization-induced T lymphocytes reactive against AKR leukemia in vitro and correlation with graft-vs-leukemia activity in vivo.
    Truitt RL; Shih CY; Lefever AV; Tempelis LD; Andreani M; Bortin MM
    J Immunol; 1983 Oct; 131(4):2050-8. PubMed ID: 6194224
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Cell-mediated immune response in vitro. I. The development of suppressor cells and cytotoxic lymphocytes in mixed lymphocyte cultures.
    Hirano T; Nordin AA
    J Immunol; 1976 Apr; 116(4):1115-22. PubMed ID: 130426
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Thymocyte and macrophage interactions: separation of murine thymocyte subsets and enrichment of syngeneic cell-responding thymocytes by adsorption to macrophage monolayers.
    Wu S; Thomas DW
    J Immunol; 1983 Nov; 131(5):2110-6. PubMed ID: 6226732
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Target determinants for F1 hybrid anti-parental H-2d cell-mediated lympholysis: self antigens controlled by the D end.
    Nakamura I; Nakano K; Cudkowicz G
    J Immunol; 1983 May; 130(5):2429-33. PubMed ID: 6187857
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Cell-mediated immune response in vitro. II. The mechanism(s) involved in the suppression of the development of cytotoxic lymphocytes.
    Hirano T; Nordin AA
    J Immunol; 1976 Dec; 117(6):2226-32. PubMed ID: 62810
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Dissociation of lymphocyte activating determinants from recognition sites in mouse MLR.
    Abbasi K; Festenstein H; Verbi W; Roitt IM
    Nature; 1974 Sep; 251(5472):227-9. PubMed ID: 4138667
    [No Abstract]   [Full Text] [Related]  

  • 80. Virus-induced polyclonal cytotoxic T lymphocyte stimulation.
    Yang HY; Dundon PL; Nahill SR; Welsh RM
    J Immunol; 1989 Mar; 142(5):1710-8. PubMed ID: 2537363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.